B. Riley Wealth Advisors Inc. Cuts Stock Holdings in The Procter & Gamble Company (NYSE:PG)

B. Riley Wealth Advisors Inc. lowered its stake in The Procter & Gamble Company (NYSE:PG - Free Report) by 36.0% in the 3rd quarter, according to its most recent disclosure with the SEC. The fund owned 146,370 shares of the company's stock after selling 82,226 shares during the quarter. Procter & Gamble accounts for 0.7% of B. Riley Wealth Advisors Inc.'s portfolio, making the stock its 17th biggest position. B. Riley Wealth Advisors Inc.'s holdings in Procter & Gamble were worth $25,113,000 as of its most recent filing with the SEC.

Several other institutional investors and hedge funds have also recently made changes to their positions in PG. Brookstone Capital Management increased its position in Procter & Gamble by 8.8% during the 2nd quarter. Brookstone Capital Management now owns 61,259 shares of the company's stock valued at $10,380,000 after purchasing an additional 4,969 shares during the period. Franklin Street Advisors Inc. NC lifted its holdings in Procter & Gamble by 1.0% in the second quarter. Franklin Street Advisors Inc. NC now owns 65,444 shares of the company's stock worth $10,793,000 after buying an additional 657 shares during the period. Shilanski & Associates Inc. boosted its position in Procter & Gamble by 0.6% during the 2nd quarter. Shilanski & Associates Inc. now owns 27,046 shares of the company's stock valued at $4,460,000 after acquiring an additional 160 shares in the last quarter. TCW Group Inc. grew its holdings in shares of Procter & Gamble by 3.6% during the 2nd quarter. TCW Group Inc. now owns 38,862 shares of the company's stock worth $6,409,000 after acquiring an additional 1,364 shares during the period. Finally, Accordant Advisory Group Inc raised its position in shares of Procter & Gamble by 202.0% in the 2nd quarter. Accordant Advisory Group Inc now owns 299 shares of the company's stock worth $49,000 after acquiring an additional 200 shares in the last quarter. Institutional investors own 65.77% of the company's stock.

Procter & Gamble Stock Performance

Shares of NYSE PG traded up $0.21 during midday trading on Friday, hitting $171.06. 3,884,513 shares of the stock traded hands, compared to its average volume of 6,686,880. The company has a debt-to-equity ratio of 0.50, a quick ratio of 0.55 and a current ratio of 0.75. The Procter & Gamble Company has a one year low of $142.50 and a one year high of $180.43. The firm has a market capitalization of $402.85 billion, a P/E ratio of 29.49, a PEG ratio of 3.69 and a beta of 0.44. The firm has a 50-day moving average of $170.74 and a two-hundred day moving average of $169.59.

Procter & Gamble (NYSE:PG - Get Free Report) last announced its earnings results on Friday, October 18th. The company reported $1.93 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.90 by $0.03. Procter & Gamble had a return on equity of 33.25% and a net margin of 17.07%. The business had revenue of $21.74 billion for the quarter, compared to analysts' expectations of $21.99 billion. During the same period last year, the firm posted $1.83 earnings per share. The business's revenue for the quarter was down .6% on a year-over-year basis. On average, equities analysts forecast that The Procter & Gamble Company will post 6.94 EPS for the current fiscal year.

Procter & Gamble Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Friday, November 15th. Shareholders of record on Friday, October 18th were given a $1.0065 dividend. The ex-dividend date of this dividend was Friday, October 18th. This represents a $4.03 annualized dividend and a yield of 2.35%. Procter & Gamble's payout ratio is presently 69.48%.

Insider Transactions at Procter & Gamble

In other Procter & Gamble news, CEO Jon R. Moeller sold 7,007 shares of Procter & Gamble stock in a transaction that occurred on Wednesday, October 2nd. The shares were sold at an average price of $171.65, for a total transaction of $1,202,751.55. Following the transaction, the chief executive officer now owns 269,172 shares of the company's stock, valued at $46,203,373.80. The trade was a 2.54 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, insider Susan Street Whaley sold 634 shares of the stock in a transaction on Wednesday, October 2nd. The stock was sold at an average price of $171.65, for a total transaction of $108,826.10. Following the completion of the sale, the insider now directly owns 19,341 shares of the company's stock, valued at approximately $3,319,882.65. This trade represents a 3.17 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 83,080 shares of company stock worth $14,629,038 in the last 90 days. 0.18% of the stock is currently owned by insiders.

Analyst Ratings Changes

Several equities research analysts recently weighed in on the company. Hsbc Global Res raised Procter & Gamble to a "strong-buy" rating in a research note on Friday, October 4th. Evercore ISI upped their target price on shares of Procter & Gamble from $180.00 to $183.00 and gave the stock an "outperform" rating in a research report on Monday, October 21st. DA Davidson raised shares of Procter & Gamble from a "neutral" rating to a "buy" rating and lifted their price target for the company from $160.00 to $209.00 in a research report on Monday, November 25th. Morgan Stanley upped their price objective on shares of Procter & Gamble from $174.00 to $191.00 and gave the stock an "overweight" rating in a report on Monday, October 21st. Finally, Wells Fargo & Company lifted their target price on shares of Procter & Gamble from $188.00 to $190.00 and gave the company an "overweight" rating in a report on Friday, November 22nd. Eight investment analysts have rated the stock with a hold rating, fourteen have assigned a buy rating and two have assigned a strong buy rating to the company's stock. Based on data from MarketBeat.com, the company currently has an average rating of "Moderate Buy" and a consensus target price of $180.45.

Procter & Gamble Company Profile

The Procter & Gamble Company engages in the provision of branded consumer packaged goods worldwide. The company operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The Beauty segment offers conditioners, shampoos, styling aids, and treatments under the Head & Shoulders, Herbal Essences, Pantene, and Rejoice brands; and antiperspirants and deodorants, personal cleansing, and skin care products under the Olay, Old Spice, Safeguard, Secret, SK-II, and Native brands.